Not the person you asked but this comes from the capital raising presentation last year:
Looks to be anticipated around late 2025. The reason they are already allowed to sell, is that the US FDA granted BUB a temporary exemption from the regulatory enforcement so that it could import its products. There are a lot of companies that have been granted the same exemption, the reason being to address formula shortages created by a contamination scandal awhile back.
Ann: Bubs Q2 FY24 Quarterly Activity and Cashflow Statement, page-19
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BUB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $115.9M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.5¢ | 13.0¢ | $511.6K | 3.852M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 941440 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 167224 | 3 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| BUB (ASX) Chart |